Matches in Wikidata for { <http://www.wikidata.org/entity/Q37174738> ?p ?o ?g. }
- Q37174738 description "article científic" @default.
- Q37174738 description "article scientifique" @default.
- Q37174738 description "articolo scientifico" @default.
- Q37174738 description "artigo científico" @default.
- Q37174738 description "artículu científicu espublizáu en 2016" @default.
- Q37174738 description "bilimsel makale" @default.
- Q37174738 description "scientific article published on 31 March 2016" @default.
- Q37174738 description "vedecký článok" @default.
- Q37174738 description "vetenskaplig artikel" @default.
- Q37174738 description "videnskabelig artikel" @default.
- Q37174738 description "vědecký článek" @default.
- Q37174738 description "wetenschappelijk artikel" @default.
- Q37174738 description "wissenschaftlicher Artikel" @default.
- Q37174738 description "наукова стаття, опублікована в березні 2016" @default.
- Q37174738 description "научни чланак" @default.
- Q37174738 description "مقالة علمية نشرت في 31 مارس 2016" @default.
- Q37174738 name "Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study" @default.
- Q37174738 name "Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study" @default.
- Q37174738 name "Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study" @default.
- Q37174738 type Item @default.
- Q37174738 label "Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study" @default.
- Q37174738 label "Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study" @default.
- Q37174738 label "Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study" @default.
- Q37174738 prefLabel "Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study" @default.
- Q37174738 prefLabel "Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study" @default.
- Q37174738 prefLabel "Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study" @default.
- Q37174738 P1433 Q37174738-1201F354-3303-4FCF-B1C3-BE5893DEFE13 @default.
- Q37174738 P1476 Q37174738-D61BAEDC-4588-4B0B-B6AD-829B4BE4E5D6 @default.
- Q37174738 P2093 Q37174738-08D06DCD-FA59-4ABB-9985-D951956AEC63 @default.
- Q37174738 P2093 Q37174738-12BCC13D-5FD8-4264-A8F3-B334EDA28A5A @default.
- Q37174738 P2093 Q37174738-200108E4-2627-4AF3-A9BB-7E29838A37B8 @default.
- Q37174738 P2093 Q37174738-20456B7D-777F-4FE5-8E33-7B82460CC76E @default.
- Q37174738 P2093 Q37174738-21031565-803B-4A71-BCBB-A8A244A75A0C @default.
- Q37174738 P2093 Q37174738-63DFA447-1CE4-4D4E-AD61-95E01594AA1B @default.
- Q37174738 P2093 Q37174738-6DA93766-39FB-4CDC-A0BD-C83146890959 @default.
- Q37174738 P2093 Q37174738-7AA35C40-D3DA-401F-AB4E-816E0CC8FB7D @default.
- Q37174738 P2093 Q37174738-7D4233AD-A87E-4128-92BB-E6FEF81174C7 @default.
- Q37174738 P2093 Q37174738-8D14F988-83E0-42B9-AA6A-5FF4871F16AE @default.
- Q37174738 P2093 Q37174738-D31B6250-6098-4B15-9BBC-04ABF315E44B @default.
- Q37174738 P2093 Q37174738-F1169EAA-02FA-4F5B-90F5-E9F2A95E4D73 @default.
- Q37174738 P275 Q37174738-1500e460-128e-415a-bc4f-6f5ea6d862dc @default.
- Q37174738 P2860 Q37174738-027D49BE-5D9D-4452-B6DE-CEE22856D7BA @default.
- Q37174738 P2860 Q37174738-0337517B-280C-43D8-BEEA-568B636CEBB9 @default.
- Q37174738 P2860 Q37174738-0DA83138-EA20-4E58-AD11-6547EF51E5B7 @default.
- Q37174738 P2860 Q37174738-233C1AA8-B47A-45C0-AF8A-C85598CB8735 @default.
- Q37174738 P2860 Q37174738-277CA8A7-CC62-4860-83C0-821B86FBAC8F @default.
- Q37174738 P2860 Q37174738-30948B03-2051-4546-AFC0-7E108882C206 @default.
- Q37174738 P2860 Q37174738-3D357911-C59E-4831-9356-CCF3ED87D183 @default.
- Q37174738 P2860 Q37174738-425B18CA-FC7A-4B22-B6BC-14268FA16600 @default.
- Q37174738 P2860 Q37174738-441F653C-7854-437A-B40E-728A2FB6A471 @default.
- Q37174738 P2860 Q37174738-5B3FEECD-36A2-4E83-A576-E1B2F54BED8E @default.
- Q37174738 P2860 Q37174738-616EFBB7-E7DA-4050-B837-C3B98942CC00 @default.
- Q37174738 P2860 Q37174738-81FDE20E-69CB-4C12-9F0D-2EDA50B7ABA6 @default.
- Q37174738 P2860 Q37174738-9494BF53-83BE-4AFF-876C-680BC5BD978C @default.
- Q37174738 P2860 Q37174738-9E98ABF5-601E-418B-997C-827422032870 @default.
- Q37174738 P2860 Q37174738-A1784CEC-57E4-4232-8DF2-1CC1B7EA8F44 @default.
- Q37174738 P2860 Q37174738-B04EC0F6-E348-4E87-AE2C-DD4C33036E4E @default.
- Q37174738 P2860 Q37174738-B3DD7D7C-14D6-4BF9-BA89-55812CB4AB7E @default.
- Q37174738 P2860 Q37174738-C0521F47-D7BC-4913-B44F-945710083771 @default.
- Q37174738 P2860 Q37174738-D4B0ED18-2EFA-4B00-A61C-B35D0500F3A7 @default.
- Q37174738 P2860 Q37174738-D8C928DB-EE82-4B0A-9274-850637E0A31C @default.
- Q37174738 P2860 Q37174738-D8D607D7-7028-46C3-BB62-B98C439188DE @default.
- Q37174738 P2860 Q37174738-D99F96FA-03FD-4515-BC76-E220A70EF401 @default.
- Q37174738 P2860 Q37174738-DBDD971D-6DD2-491F-9962-5A9D641027C2 @default.
- Q37174738 P2860 Q37174738-DF9A21FF-C093-4E34-88A9-642917ED23CA @default.
- Q37174738 P2860 Q37174738-DFE8F48C-FE45-4D1F-BA87-1112E1C2F01E @default.
- Q37174738 P2860 Q37174738-E364B396-71E4-4416-998E-9098C02B754D @default.
- Q37174738 P2860 Q37174738-F901799A-2453-4006-95A7-78F1D9F9B611 @default.
- Q37174738 P2888 Q37174738-0A77E28B-F312-41D0-AD0B-2D336ADDC71E @default.
- Q37174738 P304 Q37174738-8F682CB9-53F2-46A5-999C-B10B447DCE33 @default.
- Q37174738 P31 Q37174738-51FE67D9-CE54-4578-AEDA-C2B8D72AF798 @default.
- Q37174738 P356 Q37174738-DD2FA60A-23B2-4025-A2F8-3D6768635A24 @default.
- Q37174738 P407 Q37174738-4C243B71-7D57-4B36-AE8B-22CF97C00FDE @default.
- Q37174738 P433 Q37174738-491BE3F8-8DB5-47C8-8ADB-45FBFE198748 @default.
- Q37174738 P478 Q37174738-F3626B85-6A65-46B5-85D0-D32704D02BD6 @default.
- Q37174738 P577 Q37174738-4D9E14F7-BA96-4496-B67D-BE1326C0FFEB @default.
- Q37174738 P6216 Q37174738-2b6dc6d7-ac91-4119-86f6-38461ccb8fc7 @default.
- Q37174738 P698 Q37174738-13861FCB-FE8F-45E6-BD06-8A30A1C285E8 @default.
- Q37174738 P921 Q37174738-9DF5C627-91BF-4F17-B498-D90320C20D12 @default.
- Q37174738 P932 Q37174738-882D9002-8B04-46A8-988C-ADB94C996821 @default.
- Q37174738 P356 BJC.2016.82 @default.
- Q37174738 P698 27031854 @default.
- Q37174738 P1433 Q326309 @default.
- Q37174738 P1476 "Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study" @default.
- Q37174738 P2093 "A Wischnik" @default.
- Q37174738 P2093 "B Rack" @default.
- Q37174738 P2093 "C Scholz" @default.
- Q37174738 P2093 "D Augustin" @default.
- Q37174738 P2093 "J Huober" @default.
- Q37174738 P2093 "J Jueckstock" @default.
- Q37174738 P2093 "K Annecke" @default.
- Q37174738 P2093 "M Kiechle" @default.
- Q37174738 P2093 "N Harbeck" @default.
- Q37174738 P2093 "T W P Friedl" @default.
- Q37174738 P2093 "T Zwingers" @default.
- Q37174738 P2093 "W Janni" @default.
- Q37174738 P275 Q42553662 @default.
- Q37174738 P2860 Q29547513 @default.
- Q37174738 P2860 Q33397151 @default.
- Q37174738 P2860 Q33561953 @default.